Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
As of: Sep 4, 2026 · 3:20 PM EDT

Compugen (CGEN) Short-term Investments (2009 - 2026)

Compugen (CGEN) posted quarterly Short-term Investments of $79.3 million for Q1 2026, up 40.43% year-over-year from $56.5 million in Q1 2025, and up 73.33% on a QoQ basis from $45.8 million in Q4 2025.

Analysis

Compugen (CGEN) Short-term Investments (2009 - 2026) Analysis & Trends

Compugen has reported Short-term Investments for 18 years, with the latest figure at $79.3 million in Q1 2026.

  • Short-term Investments for Q1 2026 came in at $79.3 million, up 40.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.3 million (up 40.43% YoY), and the FY2025 annual result was $45.8 million, down 25.47% from the prior year.
  • Short-term Investments climbed to $79.3 million in Q1 2026, from $45.8 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $88.9 million in Q2 2022 and troughed at $25.1 million in Q4 2023.
  • A 5-year average of $58.6 million and a median of $57.5 million in 2025 frame the typical range for Short-term Investments.
  • The widest annual swing landed in 2023, when Short-term Investments plunged 65.34%; it then soared 145.07% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $72.3 million in 2022, then plunged by 65.34% to $25.1 million in 2023, then soared by 145.07% to $61.4 million in 2024, then declined by 25.47% to $45.8 million in 2025, then soared by 73.33% to $79.3 million in 2026.
  • Per Business Quant data, the three most recent Short-term Investments figures were $79.3 million in Q1 2026, $45.8 million in Q4 2025, and $51.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Compugen 241.50 Mn 155.89 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.34 Mn
Mar 31, 2026 79.32 Mn
Dec 31, 2025 45.76 Mn
Sep 30, 2025 51.91 Mn
Jun 30, 2025 58.54 Mn
Mar 31, 2025 56.48 Mn
Dec 31, 2024 61.40 Mn
Sep 30, 2024 72.35 Mn
Jun 30, 2024 47.44 Mn
Dec 31, 2023 25.05 Mn
Jun 30, 2023 44.30 Mn
Dec 31, 2022 72.29 Mn
Jun 30, 2022 88.92 Mn
Dec 31, 2021 109.25 Mn
Jun 30, 2021 102.56 Mn
Dec 31, 2020 116.62 Mn
Jun 30, 2020 122.96 Mn
Dec 31, 2019 34.04 Mn
Jun 30, 2019 30.75 Mn
Dec 31, 2018 39.21 Mn